eMedicine Specialties > Gastroenterology > Biliary

Cholecystitis: Follow-up

Author: Don Gladden, DO, Staff Physician, Department of Emergency Medicine, Seton Medical Center
Coauthor(s): Alexandre F Migala, DO, Staff Physician, Department of Emergency Medicine, Denton Regional Medical Center; Clinton S Beverly, MD, Clinical Assistant Professor, Department of Surgery, Mercer University School of Medicine; Jeffery Wolff, DO, Consulting Staff, Department of Gastroenterology, Brooke Army Medical Center
Contributor Information and Disclosures

Updated: Aug 4, 2008

Follow-up

Further Inpatient Care

  • Objectives during inpatient stay include the following:
    • Correction of fluid and electrolyte abnormalities
    • Antibiotics for complicating infections
    • Performing imaging studies as appropriate (eg, ultrasound, HBS)
    • Cholecystectomy once the patient is stable or percutaneous transhepatic cholecystostomy drainage in unstable high-risk surgical patients

Further Outpatient Care

  • In cases of uncomplicated cholecystitis, outpatient treatment may be appropriate. If a patient can be treated as an outpatient, discharge with antibiotics, appropriate analgesics, and definitive follow-up care. Criteria for outpatient treatment include the following:
    • Afebrile with stable vital signs
    • No evidence of obstruction by laboratory values
    • No evidence of common bile duct obstruction on ultrasound
    • No underlying medical problems, advanced age, pregnancy, or immunocompromised condition
    • Adequate analgesia
    • Reliable patient with transportation and easy access to a medical facility
    • Prompt follow-up care

Inpatient & Outpatient Medications

  • For outpatient treatment of uncomplicated cholecystitis, the following medicines may be appropriate:
    • Prophylactic antibiotic coverage with Levaquin (500 mg PO qd) and Flagyl (500 mg PO bid), which should provide coverage against the most common organisms
    • Antiemetics, such as oral/rectal Phenergan or Compazine, to control nausea and to prevent fluid and electrolyte disorders
    • Analgesics, such as oral Percocet or Vicodin

Transfer

  • Consider patient transfer if the following conditions apply:
    • Appropriate diagnostic resources are not available.
    • Higher level of care is required.
    • Surgeons and/or specialists are unavailable.

Deterrence/Prevention

  • Prevention of cholecystitis requires cholecystectomy.
  • In patients who are unstable, percutaneous transhepatic cholecystostomy drainage may be appropriate.
  • Some studies have shown that daily CCK administration may help prevent acalculous cholecystitis in patients at risk.

Complications

  • Bacterial proliferation within the obstructed gallbladder results in empyema of the organ. Patients with empyema may have a toxic reaction and may have more marked fever and leukocytosis. The presence of empyema frequently requires conversion from laparoscopic to open cholecystectomy.
  • In rare instances, a large gallstone may erode through the gallbladder wall into an adjacent viscus, usually the duodenum. Subsequently, the stone may become impacted in the terminal ileum or in the duodenal bulb and/or pylorus, causing a gallstone ileus.
  • Emphysematous cholecystitis occurs in approximately 1% of cases and is noted by the presence of gas in the gallbladder wall from the invasion of gas-producing organisms, such as E coli, Clostridia perfringens, and Klebsiella species. This complication is more common in patients with diabetes, has a male predominance, and is acalculous in 28% of cases. Because of a high incidence of gangrene and perforation, emergency cholecystectomy is recommended.
  • Sepsis
  • Pancreatitis
  • Perforation occurs in up to 15% of patients.

Prognosis

  • For uncomplicated cholecystitis, the prognosis is excellent, with a very low mortality rate.
  • In patients who are critically ill with cholecystitis, the mortality rate approaches 50-60%, especially in the setting of gangrene or empyema.
  • Once complications such as perforation/gangrene develop, the prognosis becomes less favorable. In patients who are critically ill with acalculous cholecystitis and perforation or gangrene, the mortality rate can be as high as 50-60%.

Patient Education

  • Patients diagnosed with cholecystitis must be educated regarding causes of their disease, complications if left untreated, and medical/surgical options to treat cholecystitis.
  • For excellent patient education resources, visit eMedicine's Liver, Gallbladder, and Pancreas Center. Also, see eMedicine's patient education articles Gallstones and Pancreatitis.

Miscellaneous

Medicolegal Pitfalls

  • Delays in making the diagnosis of acute cholecystitis result in a higher incidence of morbidity and mortality. This is especially true for ICU patients who develop acalculous cholecystitis. The diagnosis should be considered and investigated promptly in order to prevent poor outcomes.

Special Concerns

  • Pregnancy
    • RUQ pain in pregnancy can be related to a number of different diagnoses, including preeclampsia, appendicitis, and cholelithiasis.
    • These patients must have a thorough examination because complications can arise quickly and can be life threatening to both the mother and the unborn child.
    • Although laparoscopic cholecystectomy is considered safest during the second trimester, it has been performed successfully during all trimesters.
  • Elderly patients (especially patients with diabetes) may present with vague symptoms and without many key historical and physical findings. Elderly patients may also progress to complicated cholecystitis rapidly and without warning.
  • The pediatric population may also present without many of the classic findings. Children who are at higher risk for developing cholecystitis include patients with sickle cell disease, seriously ill children, those on prolonged TPN, those with hemolytic conditions, and those with congenital and biliary anomalies.
  • Patients who are immunocompromised are at increased risk of developing cholecystitis from a number of different infectious sources.
 


More on Cholecystitis

Overview: Cholecystitis
Differential Diagnoses & Workup: Cholecystitis
Treatment & Medication: Cholecystitis
Follow-up: Cholecystitis
Multimedia: Cholecystitis
References

References

  1. Cullen JJ, Maes EB, Aggrawal S, et al. Effect of endotoxin on opossum gallbladder motility: a model of acalculous cholecystitis. Ann Surg. Aug 2000;232(2):202-7. [Medline].

  2. Singer AJ, McCracken G, Henry MC, et al. Correlation among clinical, laboratory, and hepatobiliary scanning findings in patients with suspected acute cholecystitis. Ann Emerg Med. Sep 1996;28(3):267-72. [Medline].

  3. Towfigh S, McFadden DW, Cortina GR, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg. Jan 2001;67(1):7-10. [Medline].

  4. Sahai AV, Mauldin PD, Marsi V, et al. Bile duct stones and laparoscopic cholecystectomy: a decision analysis to assess the roles of intraoperative cholangiography, EUS, and ERCP. Gastrointest Endosc. Mar 1999;49(3 Pt 1):334-43. [Medline].

  5. Lee SS, Park do H, Hwang CY, et al. EUS-guided transmural cholecystostomy as rescue management for acute cholecystitis in elderly or high-risk patients: a prospective feasibility study. Gastrointest Endosc. Nov 2007;66(5):1008-12. [Medline].

  6. Siddiqui T, MacDonald A, Chong PS, et al. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis of randomized clinical trials. Am J Surg. Jan 2008;195(1):40-7. [Medline].

  7. Bingener J, Schwesinger WH, Chopra S, et al. Does the correlation of acute cholecystitis on ultrasound and at surgery reflect a mirror image?. Am J Surg. Dec 2004;188(6):703-7.

  8. Chiu HH, Chen CM, Mo LR. Emphysematous cholecystitis. Am J Surg. Sep 2004;188(3):325-6. [Medline].

  9. Cox MR, Wilson TG, Luck AJ, et al. Laparoscopic cholecystectomy for acute inflammation of the gallbladder. Ann Surg. Nov 1993;218(5):630-4. [Medline].

  10. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am. Mar 1999;28(1):75-97. [Medline].

  11. Forbes LE, Bajaj M, McGinn T, et al. Perihepatic abscess formation in diabetes: a complication of silent gallstones. Am J Gastroenterol. Apr 1996;91(4):786-8. [Medline].

  12. Greenwald JA, McMullen HF, Coppa GF, et al. Standardization of surgeon-controlled variables: impact on outcome in patients with acute cholecystitis. Ann Surg. Mar 2000;231(3):339-44. [Medline].

  13. Gruber PJ, Silverman RA, Gottesfeld S, et al. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. Sep 1996;28(3):273-7. [Medline].

  14. Jang T, Aubin C, Naunheim R. Minimum training for right upper quadrant ultrasonography. Am J Emerg Med. Oct 2004;22(6):439-43. [Medline].

  15. Liolios A, Oropello JM, Benjamin E. Gastrointestinal complications in the intensive care unit. Clin Chest Med. Jun 1999;20(2):329-45, viii. [Medline].

  16. Lo CM, Liu CL, Fan ST, et al. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg. Apr 1998;227(4):461-7. [Medline].

  17. McEvoy CF, Suchy FJ. Biliary tract disease in children. Pediatr Clin North Am. Feb 1996;43(1):75-98. [Medline].

  18. Moscati RM. Cholelithiasis, cholecystitis, and pancreatitis. Emerg Med Clin North Am. Nov 1996;14(4):719-37. [Medline].

  19. Roe J. Evidence-based emergency medicine. Clinical assessment of acute cholecystitis in adults. Ann Emerg Med. Jul 2006;48(1):101-3. [Medline].

  20. Rosen CL, Brown DF, Chang Y, et al. Ultrasonography by emergency physicians in patients with suspected cholecystitis. Am J Emerg Med. Jan 2001;19(1):32-6. [Medline].

  21. Rubens DJ. Hepatobiliary imaging and its pitfalls. Radiol Clin North Am. Mar 2004;42(2):257-78. [Medline].

  22. Shah K, Wolfe RE. Hepatobiliary ultrasound. Emerg Med Clin North Am. Aug 2004;22(3):661-73, viii. [Medline].

  23. Silberfein EJ, Zhou W, Kougias P, et al. Percutaneous cholecystostomy for acute cholecystitis in high-risk patients: experience of a surgeon-initiated interventional program. Am J Surg. Nov 2007;194(5):672-7. [Medline].

  24. Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet. Jan 1990;170(1):25-31. [Medline].

  25. Yates MR 3rd, Baron TH. Biliary tract disease in pregnancy. Clin Liver Dis. 1999;3:131-147.

Further Reading

Keywords

cholecystitis, cholelithiasis, gallstones, gallbladder stones, gallbladder inflammation, cystic duct obstruction, cystic duct stones, acute cholecystitis, chronic cholecystitis, emphysematous cholecystitis, acalculous cholecystitis, calculous cholecystitis, stones in the cystic duct, obstruction of the cystic duct, biliary pain, acalculous biliary colic, calculous biliary colic, biliary stasis, cholecystectomy, sepsis, long-term total parenteral nutrition, long-term TPN, prolonged fasting, sickle cell disease, Salmonella infections, diabetes mellitus, cytomegalovirus, cryptosporidiosis, microsporidiosis infections, obesity, jaundice, major surgery, severe trauma, severe burns, myocardial infarction

Contributor Information and Disclosures

Author

Don Gladden, DO, Staff Physician, Department of Emergency Medicine, Seton Medical Center
Don Gladden, DO is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Coauthor(s)

Alexandre F Migala, DO, Staff Physician, Department of Emergency Medicine, Denton Regional Medical Center
Alexandre F Migala, DO is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Osteopathic Association, Association of Military Osteopathic Physicians and Surgeons, and Texas Medical Association
Disclosure: Nothing to disclose.

Clinton S Beverly, MD, Clinical Assistant Professor, Department of Surgery, Mercer University School of Medicine
Clinton S Beverly, MD is a member of the following medical societies: American College of Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons
Disclosure: Nothing to disclose.

Jeffery Wolff, DO, Consulting Staff, Department of Gastroenterology, Brooke Army Medical Center
Jeffery Wolff, DO is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

Medical Editor

Anil Minocha, MD, FACP, FACG, Clinical Professor, School of Pharmacy, Professor of Medicine, Director of Digestive Diseases, Medical Director of Nutrition Support, Medical Director of Gastrointestinal Endoscopy, Internal Medicine Department, University of Mississippi Medical Center
Anil Minocha, MD, FACP, FACG is a member of the following medical societies: American Academy of Clinical Toxicology, American Association for the Study of Liver Diseases, American College of Forensic Examiners, American College of Gastroenterology, American College of Physicians, American Federation for Clinical Research, American Gastroenterological Association, and American Society of Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

James L Achord, MD, Professor Emeritus, Department of Medicine, Division of Digestive Diseases, University of Mississippi School of Medicine
James L Achord, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, Mississippi State Medical Association, New York Academy of Sciences, Sigma Xi, and Southern Medical Association
Disclosure: Nothing to disclose.

CME Editor

Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine
Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine
Disclosure: Nothing to disclose.

Chief Editor

Julian Katz, MD, Clinical Professor of Medicine, Drexel University College of Medicine; Consulting Staff, Department of Medicine, Section of Gastroenterology and Hepatology, Hospital of the Medical College of Pennsylvania
Julian Katz, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Geriatrics Society, American Medical Association, American Society for Gastrointestinal Endoscopy, American Society of Law Medicine and Ethics, American Trauma Society, Association of American Medical Colleges, and Physicians for Social Responsibility
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.